Colgate-Palmolive Company $CL Shares Sold by Infusive Asset Management Inc.

Infusive Asset Management Inc. lowered its position in shares of Colgate-Palmolive Company (NYSE:CL) by 18.3% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 47,816 shares of the company’s stock after selling 10,681 shares during the period. Colgate-Palmolive makes up about 2.0% of Infusive Asset Management Inc.’s investment portfolio, making the stock its 22nd largest position. Infusive Asset Management Inc.’s holdings in Colgate-Palmolive were worth $4,075,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Teacher Retirement System of Texas boosted its holdings in shares of Colgate-Palmolive by 35.3% in the 4th quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company’s stock valued at $37,110,000 after buying an additional 122,634 shares in the last quarter. Flputnam Investment Management Co. raised its stake in Colgate-Palmolive by 7.4% during the 4th quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company’s stock worth $15,881,000 after acquiring an additional 13,804 shares in the last quarter. Caprock Group LLC lifted its position in Colgate-Palmolive by 116.5% in the fourth quarter. Caprock Group LLC now owns 64,808 shares of the company’s stock valued at $5,121,000 after acquiring an additional 34,879 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in Colgate-Palmolive by 10.5% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 221,443 shares of the company’s stock valued at $17,498,000 after acquiring an additional 21,109 shares in the last quarter. Finally, First Eagle Investment Management LLC boosted its stake in Colgate-Palmolive by 0.4% in the fourth quarter. First Eagle Investment Management LLC now owns 7,918,979 shares of the company’s stock valued at $625,758,000 after acquiring an additional 29,876 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on CL shares. Wells Fargo & Company lifted their target price on Colgate-Palmolive from $92.00 to $95.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 8th. UBS Group lifted their price target on Colgate-Palmolive from $100.00 to $106.00 and gave the stock a “buy” rating in a research report on Thursday, July 16th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $102.00 price objective on shares of Colgate-Palmolive in a research note on Monday, May 4th. Citigroup raised their target price on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. Twelve investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $97.82.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $89.98 on Friday. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. The firm has a market cap of $72.00 billion, a price-to-earnings ratio of 35.01, a price-to-earnings-growth ratio of 4.83 and a beta of 0.33. The firm’s fifty day moving average price is $90.72 and its 200 day moving average price is $88.95. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. Colgate-Palmolive’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 EPS. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio is 82.49%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.